Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

Alan S. Brown, MD, FNLA
Alan S. Brown, MD, FNLA
    Program NameLast Air DateHosts/Guests
    At the Heart of Healthcare: Addressing the Future of Cardiology Care01/10/2021
    Gazing into the Cardiology Crystal Ball: The Future of Preventive Care
    Uncovering Evidence on Blood Pressure Improvements in Americans
    How Does COVID-19 Affect the Heart?10/04/2020
    Meet Alan Brown, MD
    Treating Erectile Dysfunction: Key Cardiovascular Considerations01/01/2020
    Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?12/24/2019
    Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines12/06/2019
    PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects12/12/2019
    Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease12/19/2019
    Canadian Perspectives on Managing Lipid Disorders in Children12/26/2019
    Lipid-Lowering Drug Interactions in Cardiovascular Agents01/06/2020
    Selecting the Right Contraception for the Dyslipidemic Woman01/15/2021
    Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross01/07/2020
    Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide 11/15/2018
    Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies02/27/2018
    What's the Deal with Saturated Fat and Cardiovascular Disease Risk?03/01/2018
    Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines08/10/2019
    The Lipidology Essentials: Making of a Specialty's Annual Summary01/12/2020
    Clinical Decisions on Cardiovascular Disease: Are Risks or Causes Your Guide?03/29/2018
    Pathways Toward Better Lipid Medication Adherence12/07/2017
    Special Populations in Patient-Centered Management of Dyslipidemia01/02/2018
    Dyslipidemia in The Elderly: How Old is "Too Old" to Treat? 08/29/2019
    Guidelines for Diagnosis and Management of Dyslipidemia in Patients with HIV01/25/2018
    Updated NLA Recommendations for African American Patients05/16/2018
    Dyslipidemia in Children and Adolescents01/22/2018
    Million Hearts Initiative with Dr. Janet Wright, Executive Director01/29/2018
    Dyslipidemia During Pregnancy: The Risks for Two Patients06/15/2018
    Statin Intolerance: Keys to Patient Counseling and Guidance01/31/2018
    Roles of Non-HDL Cholesterol in Risk Assessment and Treatment09/19/2017
    Keys to the Latest NLA Recommendations for Dyslipidemia Treatments02/01/2018
    Management of the Patient With Triglycerides 200-499 mg/dl.09/21/2017
    What is the Safety of Statins in Patients with Diabetes?09/27/2017
    A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines11/20/2017
    National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia12/18/2017
    New Insights on Statin Therapy for Older Patients10/05/2017
    HPS-2 THRIVE Data and Results10/19/2017
    Health Information Technology's Impact on Adherence to Lipid Therapy10/10/2017
    Cardiometabolic Consequences of Sitting Time03/17/2016
    Generics and Manufacturing: What Prescribers Need to Know10/26/2017
    Genetic Testing for Familial Hypercholesterolemia01/08/2016
    Research Updates in Familial Hypercholesterolemia02/24/2016
    Research Updates on Postprandial Dyslipidemia Treatment02/25/2016
    Lipid Biomarker Updates: When to Move Beyond the Standard Profile02/25/2016
    What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Pat...10/13/2015
    Adiposity, Obesity, and Dyslipidemia02/18/2016
    Researching Oxidized High-Density Lipoprotein in Obese Adolescents08/29/2016
    Underrecognition of Diabetes in Cardiology Practice02/19/2016
    An Avocado a Day: Does It Keep Heart Disease Away?02/26/2016
    The Impact of Inflammation on HDL Activity09/27/2016
    Changing Nutritional Needs Throughout the Lifetime11/19/2015
    Managing CVD in Women During Childbearing Years09/03/2015
    Obesity, Diabetes and the Metabolic Syndrome03/06/2015
    Broken Hearts or Broken Bones?11/17/2015
    Non-pharmacologic Approaches to the Metabolic Syndrome and Diabetes09/25/2015
    Evolving Treatments: A Review of What’s in the Pipeline06/14/2013
    Fish Oils: Are They Still Cardioprotective?07/05/2013
    Treatment Options for Polycystic Ovarian Syndrome (PCOS)04/20/2018
    Controversy Surrounding the NHLBI Pediatric Guidelines04/03/2015
    Statin Safety Considerations08/23/2013
    Emerging LDL Therapies04/10/2015
    Emerging HDL Therapies: What’s Next on the Clinical Research Horizon03/20/2015
    Understanding Why Patients Discontinue Statin Therapy05/08/2015
    Statin Therapy and Diabetes Incidence08/28/2015
    Lipids and Hormone Therapy03/01/2013
    Diet Controversies in Lipid Lowering & Cardiovascular Disease Prevention02/22/2013
    Biomarkers and Lipidology03/08/2013
    Diagnosis, Prevalence, and Screening of Familial Hypercholesterolemia02/15/2013
    Fat, Exercise and Cholesterol03/22/2018
    Managing Lipids in the Chronic Kidney Disease Patient04/05/2018
    Coronary CT Angiography08/16/2013
    Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease07/12/2013
    Management Issues in Familial Hypercholesterolemia09/29/2016
    Familial Hypercholesterolemia: Risk Stratifications in Practice09/20/2013
    From Experts to Analytics: What Does Evidence-Based Medicine Mean?01/25/2013
    CIMT Appropriate Use Guidelines08/09/2013
    Personalizing Dietary Approaches for Cardiovascular Health08/02/2013
    LDL Apheresis10/04/2016
    Imaging Guidelines for Screening CV Risk06/15/2012
    Fundamentals of Fatty Acids06/08/2012
    It's Relative: Screening and Treating Familial Hypercholesterolemia06/22/2012
    Caring for Un- and Under-Insured Patients on Lipid Therapy09/13/2016
    Current Inquiries in Lipidology: The NLA's Role in the Field06/03/2011
    Predictive Value of Lipid Biomarkers and Inflammatory Markers05/06/2011
    The Importance of Omega-3 Fatty Acids04/29/2011
    Metabolic Syndrome in African Americans: Risk Adjustments & Treatments04/22/2011
    Atherosclerosis and Cardiovascular Risk Factors in Children04/15/2011
    Cardiometabolic Risk Reduction in Native Americans04/01/2011
    The Process of Developing Clinical Guidelines10/08/2010
    Updates on the ACCORD Trial From the 2010 National Lipid Association Meeting10/01/2010
    Lipid Management and Systemic Approaches to Patient Care09/10/2010
    Heart Disease in the United States: Past, Present, and Future Trends10/15/2010
    Behavioral Strategies for Managing Weight03/11/2011
    Exercise as Medicine03/25/2011
    Using HDL in the Clinical Setting12/24/2010
    Particle Number Testing in the Prevention of Atherosclerosis03/26/2010
    Strategies to Help Reduce Diseases Associated with Lifestyle03/25/2016
    Reevaluating Heart Protective vs Destructive Dietary Fats03/04/2011
    Dietary Fats and Cardiovascular Disease08/20/2010
    Looking Beyond LDL to Reduce Cardiovascular Events11/02/2008
    The Latest Targets of Lipid Therapy09/07/2008
    Programs 1/17/21